This is a follow-up trial to NYMC 526 (NCT01461837) to assess the safety, efficacy and toxicity of administering Defibrotide prophylaxis for high-risk sickle cell or beta thalassemia patients undergoing a familial haploidentical allogeneic stem cell鈥�
- Investigator
- Jordan Milner
- Ages
- 6 Months - 34 Years
- Sexes
- All